Thus, T cell-specific PI3K p110α inactivation alters T cell differentiation and function and gives some clues as to the T cell-specific effects of p110α-inhibitors that are of interest in anticancer therapies or in autoimmune disease. Here, PIK3CA is linked to autoimmune disease.